T. Rowe Price Associates’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$890M Sell
65,864,104
-13,215,766
-17% -$185M 0.1% 170
2025
Q4
$985M Sell
79,079,870
-4,984,896
-6% -$53.8M 0.11% 159
2025
Q3
$832M Buy
84,064,766
+5,292,150
+7% +$51.5M 0.09% 182
2025
Q2
$703M Buy
78,772,616
+4,311,308
+6% +$36.5M 0.08% 211
2025
Q1
$649M Buy
74,461,308
+15,781,561
+27% +$166M 0.08% 234
2024
Q4
$731M Buy
58,679,747
+9,894,517
+20% +$122M 0.08% 210
2024
Q3
$566M Sell
48,785,230
-8,037,800
-14% -$92.7M 0.07% 260
2024
Q2
$604M Sell
56,823,030
-1,061,401
-2% -$11.7M 0.07% 237
2024
Q1
$691M Buy
57,884,431
+8,418,678
+17% +$101M 0.08% 215
2023
Q4
$536M Sell
49,465,753
-749,259
-1% -$7.17M 0.07% 251
2023
Q3
$495M Buy
50,215,012
+1,715,646
+4% +$17.9M 0.07% 235
2023
Q2
$484M Buy
48,499,366
+7,208,400
+17% +$68.9M 0.07% 253
2023
Q1
$397M Buy
41,290,966
+8,679,972
+27% +$96.3M 0.06% 271
2022
Q4
$363M Buy
32,610,994
+4,036,373
+14% +$42.2M 0.06% 283
2022
Q3
$243M Buy
28,574,621
+26,993,280
+1,707% +$266M 0.04% 329
2022
Q2
$16.6M Sell
1,581,341
-133,537
-8% -$1.46M ﹤0.01% 1216
2022
Q1
$18.7M Sell
1,714,878
-97,906
-5% -$1.29M ﹤0.01% 1242
2021
Q4
$24.5M Sell
1,812,784
-78,270
-4% -$1.05M ﹤0.01% 1234
2021
Q3
$25.6M Sell
1,891,054
-42,013
-2% -$596K ﹤0.01% 1233
2021
Q2
$27.6M Sell
1,933,067
-15,509
-0.8% -$224K ﹤0.01% 1220
2021
Q1
$27.2M Sell
1,948,576
-169,291
-8% -$2.76M ﹤0.01% 1195
2020
Q4
$39.7M Buy
2,117,867
+1,161,902
+122% +$19M ﹤0.01% 1038
2020
Q3
$14.2M Sell
955,965
-49,444
-5% -$789K ﹤0.01% 1222
2020
Q2
$16.2M Sell
1,005,409
-84,297
-8% -$1.37M ﹤0.01% 1196
2020
Q1
$16.2M Buy
1,089,706
+116,555
+12% +$2.23M ﹤0.01% 1130
2019
Q4
$19.6M Buy
973,151
+19,538
+2% +$364K ﹤0.01% 1188
2019
Q3
$18.9M Sell
953,613
-627,561
-40% -$12.3M ﹤0.01% 1166
2019
Q2
$30.1M Sell
1,581,174
-182,361
-10% -$4.03M ﹤0.01% 1048
2019
Q1
$50M Sell
1,763,535
-564,200
-24% -$16.5M 0.01% 881
2018
Q4
$63.8M Buy
2,327,735
+1,124,919
+94% +$36.4M 0.01% 733
2018
Q3
$44M Sell
1,202,816
-345,490
-22% -$13M 0.01% 960
2018
Q2
$56M Sell
1,548,306
-1,143,041
-42% -$44.8M 0.01% 851
2018
Q1
$111M Sell
2,691,347
-903,278
-25% -$38.5M 0.02% 620
2017
Q4
$152M Buy
3,594,625
+71,951
+2% +$2.75M 0.02% 522
2017
Q3
$111M Sell
3,522,674
-6,885,977
-66% -$234M 0.02% 603
2017
Q2
$404M Buy
10,408,651
+3,518,476
+51% +$135M 0.07% 286
2017
Q1
$269M Buy
6,890,175
+5,732,311
+495% +$231M 0.05% 361
2016
Q4
$44.2M Sell
1,157,864
-3,503,415
-75% -$130M 0.01% 850
2016
Q3
$178M Sell
4,661,279
-3,336,298
-42% -$148M 0.04% 458
2016
Q2
$346M Sell
7,997,577
-4,870,671
-38% -$215M 0.07% 286
2016
Q1
$596M Buy
12,868,248
+3,869,018
+43% +$187M 0.13% 191
2015
Q4
$487M Buy
8,999,230
+310,402
+4% +$14.9M 0.1% 216
2015
Q3
$350M Buy
8,688,828
+3,045,633
+54% +$170M 0.08% 272
2015
Q2
$383M Sell
5,643,195
-1,360,012
-19% -$96.1M 0.08% 283
2015
Q1
$416M Buy
7,003,207
+2,521,795
+56% +$144M 0.09% 267
2014
Q4
$253M Buy
4,481,412
+3,865,442
+628% +$208M 0.05% 376
2014
Q3
$28M Buy
615,970
+23,490
+4% +$1.14M 0.01% 1024
2014
Q2
$30.5M Buy
592,480
+6,590
+1% +$324K 0.01% 1005
2014
Q1
$28.6M Buy
585,890
+9,900
+2% +$481K 0.01% 1013
2013
Q4
$25M Sell
575,990
-14,600
-2% -$600K 0.01% 1030
2013
Q3
$22.5M Buy
590,590
+13,600
+2% +$479K 0.01% 1052
2013
Q2
$17.9M Buy
+576,990
New +$17.2M ﹤0.01% 1092

Other funds holding VTRS

T. Rowe Price Associates's VTRS Position: Q1 2026 in Review

T. Rowe Price Associates reduced its Viatris (VTRS) stake by 17% in Q1 2026, selling an estimated $185M and leaving 65,864,104 shares worth $890M. The position accounts for 0.1% of the portfolio, ranked #170.

T. Rowe Price Associates first reported a position in VTRS in Q2 2013 and has held it in 52 quarters since. The position peaked at $985M in Q4 2025. 1,019 funds tracked by Wall St. Rank hold VTRS as of Q1 2026.

  • T. Rowe Price Associates held 65,864,104 shares of Viatris worth $890M as of Q1 2026.
  • T. Rowe Price Associates sold 13,215,766 Viatris shares in Q1 2026, an estimated $185M.
  • Viatris made up 0.1% of T. Rowe Price Associates's portfolio in Q1 2026, its #170 holding.
  • T. Rowe Price Associates first reported a position in Viatris in Q2 2013 and has held it in 52 quarters since.
  • T. Rowe Price Associates's Viatris position peaked at $985M in Q4 2025.
  • 1,019 funds tracked by Wall St. Rank held Viatris as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.